Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sherri M. Biendarra-Tiegs"'
Autor:
Sherri M. Biendarra‐Tiegs, Sergey Yechikov, Bhupinder Shergill, Brittany Brumback, Kentaro Takahashi, Venktesh S. Shirure, Ruth Estelle Gonzalez, Laura Houshmand, Denise Zhong, Kuo‐Chan Weng, Jon Silva, Timothy W. Smith, Stacey L. Rentschler, Steven C. George
Publikováno v:
Physiological Reports, Vol 10, Iss 18, Pp n/a-n/a (2022)
Abstract Atrial fibrillation (AF) is the most common arrhythmia in the United States, affecting approximately 1 in 10 adults, and its prevalence is expected to rise as the population ages. Treatment options for AF are limited; moreover, the developme
Externí odkaz:
https://doaj.org/article/1096a5009d2f471fb78ff93f3a59282d
Autor:
Katherine V. Gates, Anjali J. Panicker, Sherri M. Biendarra-Tiegs, Nikolai G. Vetr, Manuela Lopera Higuita, Timothy J. Nelson, Naveen L. Pereira, Leigh G. Griffiths
Publikováno v:
Transplantation. 106:1376-1389
The International Society for Heart and Lung Transplant consensus panel notes that too little data exist regarding the role of non-HLA in allograft rejection. We developed a novel shotgun immunoproteomic approach to determine the identities and poten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e841f654295fdfe799adbf5cc528dc4a
https://doi.org/10.1097/tp.0000000000004012
https://doi.org/10.1097/tp.0000000000004012
Publikováno v:
Stem Cells and Development
The functional maturation status of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) has a notable impact upon their use in pharmacological studies, disease modeling, and therapeutic applications. Non-cardiomyocytes (non-CMs) pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be8301a91ff774dfafdd1932f176c983
https://doi.org/10.1089/scd.2019.0098
https://doi.org/10.1089/scd.2019.0098
Autor:
Sherri M. Biendarra-Tiegs, Emma B. Brandt, Xing Li, Michael J. Ackerman, Timothy J. Nelson, Dan Ye
Publikováno v:
Stem Cells and Development
The ability to accurately phenotype cells differentiated from human induced pluripotent stem cells (hiPSCs) is essential for their application in modeling developmental and disease processes, yet also poses a particular challenge without the context
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88dd032bc759d4d2d515fbd10400702
http://europepmc.org/articles/PMC6534093
http://europepmc.org/articles/PMC6534093
Autor:
R. E Gonzalez, Zhi Hong Lu, Stacey Rentschler, Laura Houshmand, Sergey Yechikov, David T. Curiel, Steven C. George, Sherri M Biendarra-tiegs
Publikováno v:
Circulation Research. 127
Atrial fibrillation (AF) poses a notable healthcare burden due to a high incidence in the increasing population over age 65 and limitations of current treatment approaches. One challenge to effectively treat AF is patient-to-patient heterogeneity in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e782b5f110b8e141a6d13c36cd078904
https://doi.org/10.1161/res.127.suppl_1.477
https://doi.org/10.1161/res.127.suppl_1.477
Publikováno v:
Advances in experimental medicine and biology. 1212
Induced pluripotent stem cells (iPSCs) offer great promise in the areas of disease modeling, basic research, drug development, and regenerative medicine. Much of their value comes from the fact that they can be used to create otherwise inaccessible c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06aee468566176edc2e0d3d74251b328
https://pubmed.ncbi.nlm.nih.gov/30850960
https://pubmed.ncbi.nlm.nih.gov/30850960
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030328221
Induced pluripotent stem cells (iPSCs) offer great promise in the areas of disease modeling, basic research, drug development, and regenerative medicine. Much of their value comes from the fact that they can be used to create otherwise inaccessible c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b335b268f7b485a2b398fc6c4067fa0a
https://doi.org/10.1007/5584_2019_350
https://doi.org/10.1007/5584_2019_350
Autor:
Anjali Jacob Panicker, Katherine V Gates, Sherri M Biendarra-Tiegs, Nikolai G Vetr, Manuela Lopera Higuita, Timothy J Nelson, Naveen L Pereira, Leigh G Griffiths
Publikováno v:
The Journal of Immunology. 204:161.7-161.7
Although immunosuppressive drugs improve short term survival, rejection incidence and long term survival remain largely unchanged in heart transplant patients. While Human Leukocyte Antigen (HLA) is a common initiator of graft-specific immune respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e682ba3a69747929a04ddf652d8dc4c
https://doi.org/10.4049/jimmunol.204.supp.161.7
https://doi.org/10.4049/jimmunol.204.supp.161.7